Previous close | 16.74 |
Open | 16.74 |
Bid | 16.60 |
Ask | 24.90 |
Strike | 405.00 |
Expiry date | 2024-05-31 |
Day's range | 16.74 - 16.74 |
Contract range | N/A |
Volume | |
Open interest | 21 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...